Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Cameron

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
BMC Gastroenterology|October 15, 2013
Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naïve and -experienced patientsArmin D Goralczyk, Silke Cameron, Ahmad Amanzada
International Journal of Clinical and Experimental Pathology|January 23, 2020
Mediators of hypoxia in a rat model of sterile-induced acute liver injuryShakil Ahmad, Silke Cameron, Naila Naz, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancerMartina Blaschke, Silke Cameron, Colin Goeschen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 22, 2019
Optimal thresholds of risk parameters for gastrointestinal stromal tumorsBjoern Sander, Silke Cameron, Bastian Gunawan, et al.
Case Reports in Oncology|November 25, 2011
Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal TumorSilke Cameron, Inga-Marie Schaefer, Harald Schwoerer, et al.
World Journal of Hepatology|October 29, 2014
Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysisNicolae-Catalin Mechie, Christian Röver, Silke Cameron, et al.
International Journal of Clinical and Experimental Pathology|August 15, 2014
Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST)Silke Cameron, Marieke Gieselmann, Martina Blaschke, et al.
Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe|September 1, 2021
Which East Asian herbal medicines can decrease viral infections?Kenny Kuchta, Silke Cameron, Minwon Lee, et al.
Case Reports in Oncology|May 26, 2011
A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumabAhmad Amanzada, Gwen-Jana Töppler, Silke Cameron, et al.
Zeitschrift Fur Gastroenterologie|October 6, 2023
Treatment of dyspeptic symptoms with YamatoGast. A non-interventional study of a registered traditional herbal Rikkunshito extract product from Japanese Kampo Medicine in routine practice in GermanyHeidrun Reißenweber-Hewel, Christian Pehl, Silke Cameron, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
BMC Gastroenterology|October 15, 2013
Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naïve and -experienced patientsArmin D Goralczyk, Silke Cameron, Ahmad Amanzada
International Journal of Clinical and Experimental Pathology|January 23, 2020
Mediators of hypoxia in a rat model of sterile-induced acute liver injuryShakil Ahmad, Silke Cameron, Naila Naz, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancerMartina Blaschke, Silke Cameron, Colin Goeschen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 22, 2019
Optimal thresholds of risk parameters for gastrointestinal stromal tumorsBjoern Sander, Silke Cameron, Bastian Gunawan, et al.
Case Reports in Oncology|November 25, 2011
Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal TumorSilke Cameron, Inga-Marie Schaefer, Harald Schwoerer, et al.
World Journal of Hepatology|October 29, 2014
Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysisNicolae-Catalin Mechie, Christian Röver, Silke Cameron, et al.
International Journal of Clinical and Experimental Pathology|August 15, 2014
Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST)Silke Cameron, Marieke Gieselmann, Martina Blaschke, et al.
Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe|September 1, 2021
Which East Asian herbal medicines can decrease viral infections?Kenny Kuchta, Silke Cameron, Minwon Lee, et al.
Case Reports in Oncology|May 26, 2011
A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumabAhmad Amanzada, Gwen-Jana Töppler, Silke Cameron, et al.
Zeitschrift Fur Gastroenterologie|October 6, 2023
Treatment of dyspeptic symptoms with YamatoGast. A non-interventional study of a registered traditional herbal Rikkunshito extract product from Japanese Kampo Medicine in routine practice in GermanyHeidrun Reißenweber-Hewel, Christian Pehl, Silke Cameron, et al.
Pageof 7